OpenVSafe by OpenVAERS
Search V-safe

X6Z-25176-06408

2 vaccinations 3 coded responses 23 check-ins 3 free-text entries 1 call case
Sex
Female
Age at first dose
21-25
ZIP prefix
211 / MD
Registered
2021-09-13
Relationship
Self
Race
White
Ethnicity
N/A

Timeline

  1. 2021-09-13
    Registered in v-safe
  2. 2021-09-13
    Dose 1 — Pfizer-BioNTech
  3. 2021-09-13
    Survey response — day 0, dose 1
    MedDRA: Guillain-Barre syndrome — Feeling: Good
    Free text: Have Guillian-Barre Syndrome
    MedDRA releases: 2024-11 · check-in free text available
  4. 2021-09-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · None
    Adult check-in
  5. 2021-09-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-09-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Diarrhea, Abdominal pain
    Adult check-in
  7. 2021-09-17
    Survey response — days 1–6 daily, dose 1
    MedDRA: Adverse reaction — Feeling: Fair · Diarrhea, Abdominal pain
    Free text: Menstruation likely cause of these symptoms
    MedDRA releases: 2024-11 · check-in free text available
  8. 2021-09-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-09-20
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-09-27
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-10-04
    Dose 2 — Pfizer-BioNTech
  12. 2021-10-04
    Health check-in — day 0, dose 2
    Feeling: Fair · None
    Adult check-in
  13. 2021-10-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness
    Adult check-in
  14. 2021-10-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Headache
    Adult check-in
  15. 2021-10-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-10-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-10-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · None
    Adult check-in
  18. 2021-10-11
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-10-18
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-10-25
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-11-01
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-11-08
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-11-15
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  24. 2022-01-03
    Survey response — 3 months, dose 2
    MedDRA: Migraine, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Migraines, sometimes running fever
    MedDRA releases: 2024-11 · check-in free text available
  25. 2022-01-03
    Report sent to call center — 3 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  26. 2022-01-07
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
  27. 2022-04-06
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2022-10-06
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-09-13Pfizer-BioNTech No
22021-10-04Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-01-03 Successful
2022-01-07
 Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Free text

Release 9 — day 0, dose 1

2021-09-13

Systemic reaction (other): Have Guillian-Barre Syndrome

Release 9 — days 1–6 daily, dose 1

2021-09-17

Systemic reaction (other): Menstruation likely cause of these symptoms

Release 10 — 3 months, dose 2

2022-01-03

Symptoms: Migraines, sometimes running fever

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDMigraine · · ✓
SDPyrexia · · ✓
SROAdverse reaction · · ✓
SROGuillain-Barre syndrome · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…